Certaines applications sont distribuées sous forme d'APKs divisées (plusieurs fichiers .apk groupés) pour optimiser les ressources. Les installateurs Android standard ne peuvent pas les ouvrir.
Trusted by pharmacists & healthcare pros AHFS DI comprehensive evidence-based source of drug info with therapeutic guidelines & off-label uses.
Keep your app updated to get the latest experience on your mobile phones. We want you to get notified about exclusive offers, prmotions, and discounts. This updates does this directly through in-app notifications. We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions."
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
AHFS® Drug Information™ - Doody's Core Title - is your comprehensive, interactive treatment and drug therapy solution - complete with therapeutic guidelines and off-label uses.
2020, 2021, 2022, 2023, 2024,2025 Doody's Core Titles List Selection
AHFS Drug Information® 2026 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
Updates in the new edition:
- Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
- Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful - oversight to manage severe adverse effects and dosage adjustments
- Contemporary topics such as biosimilars, novel orphan drugs, and updated vaccine guidance based on recommendations from the CDC’s Advisory Committee on Immunization Practices (ACIP) and other authoritative organizations
- Essential drug information content for patient safety including FDA Medwatch alerts, Standardize4Safety concentrations for IV and oral liquid medications, ISMP recommendations, REMS data, BEERS criteria, boxed warnings, and focused updates based on FDA safety findings
- Pharmacogenomic considerations in drug dosing and selection
- Expanded content on new and emerging gene and cellular therapies
- Class-wide revisions to standard and established therapies for common disease states including hypertension and diabetes
- Expanded content on off-label uses, real world data, and long-term clinical data
- New content on new molecular entities (NMEs) and biologic approvals
- New oncology off-label determinations based on reviews by the AHFS Oncology Expert Committee
Content licensed from printed ISBN 10: 1585287776
Content licensed from printed ISBN 13: 9781585287772
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $99.99
Payment will be charged to your mode of payment you select at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your App “Settings” and tapping “Manage Subscriptions”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor(s): American Society of Health-System Pharmacists, Inc.
Publisher: American Society of Health-System Pharmacists, Inc.
com.medpresso.Lonestar.ahfsdi sur APK Downloader.Oui ! Chaque téléchargement d'APK fourni par APKDER est soumis à une vérification de sécurité rigoureuse. Nous vérifions que la signature cryptographique du fichier APK correspond à la signature officielle du développeur, garantissant ainsi que l'APK est original, intact et exempt de toute modification.
Pour l'installer, vous devez d'abord activer les "Sources inconnues" dans les paramètres de sécurité de votre appareil Android. Après avoir téléchargé le fichier APK depuis APKDER, appuyez dessus pour lancer l'installation et suivez les instructions.
Oui ! Dès que le développeur publie une nouvelle version de AHFS Drug Information, nous mettons à jour l'APK sur APKDER. Vous pouvez simplement télécharger et installer le nouvel APK par-dessus l'ancien sans perdre vos données.
Oui. APKDER vous permet de contourner les restrictions géographiques et de télécharger directement les fichiers APK officiels, même si l'application ou le jeu n'est pas officiellement disponible dans le store de votre pays.
Un APK standard est un paquet d'installation unique. Un XAPK ou un APK divisé (Split APK) contient plusieurs fichiers de ressources (comme les extensions OBB ou des fichiers de mise en page spécifiques) packagés ensemble. Pour les installer, vous pouvez les télécharger individuellement ou utiliser des outils comme Split APKs Installer (SAI).
Ce téléchargement APK est 100% sûr. Nous vérifions que la signature cryptographique du fichier correspond aux informations d'identification officielles du développeur. Aucune modification ni adware n'est injecté.